Intellectual Property India Publishes Patent Application for 'Methods Of Treatment Of High-Grade Squamous Intraepithelial Lesion (HSIL)' Filed by Inovio Pharmaceuticals, Inc.

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202517093309 A) filed by Inovio Pharmaceuticals, Inc., Plymouth Meeting, U.S.A., on Sept. 29, for 'methods of treatment of high-grade squamous intraepithelial lesion (hsil) .'

Inventor(s) include Kraynyak, Kimberly; Boyer, Jean D.; Morrow, Matthew P.; and Bhuyan, Prakash.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "Described are methods of treating human papillomavirus (HPV) type 16- or HPV type 18-related High-grade Squamous Intraepithelial Lesion (HSIL) of the cervix."

The patent application was internationally filed on Mar. 01, 2024, under International application No.PCT/US2024/018114.

Disclaimer: Curated by HT Syndication.